Gastroenterology
Volume 129, Issue 3 , Pages 819-826, September 2005

Increased Risk for Demyelinating Diseases in Patients With Inflammatory Bowel Disease

  • Gauree Gupta

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • ,
  • Joel M. Gelfand

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • ,
  • James D. Lewis

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    • Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress requests for reprints to: James D. Lewis, MD, MSCE, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 720 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021. fax: (215) 573-0813.

Received 27 January 2005; accepted 26 May 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by grant 5-T35-DK060441-03. J.M.G. has received research support and consulting honorarium from Amgen. J.D.L. has received consulting honorarium and research support from Wyeth during the past 2 years for work unrelated to anti–tumor necrosis factor α therapies and is a co-investigator of research funded by Johnson and Johnson but does not receive any direct compensation as part of the research.

PII: S0016-5085(05)01124-8

doi:10.1053/j.gastro.2005.06.022

Refers to article:

  • Inflammatory Bowel Disease Extending Its Reach

    Edward V. Loftus
    Gastroenterology September 2005 (Vol. 129, Issue 3, Pages 1117-1120)

Gastroenterology
Volume 129, Issue 3 , Pages 819-826, September 2005

Article Tools